default author photo

Chao Wang

Government of the People's Republic of China - Department of Urinary Surgery

800 Xiangyin Rd

Yangpu Qu

China

Government of the People's Republic of China - Department of Urology

168 Changhai Road

Shanghai, 200438

China

SCHOLARLY PAPERS

2

DOWNLOADS

268

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Degalactotigonin Exerts Effective Inhibition on the Growth, Metastasis and Sunitinib-Resistance of Renal Cell Carcinoma Through Inactivating YAP Signaling

Number of pages: 54 Posted: 30 Oct 2018
Chao Wang, Hai Huang, Tian-yu Hong, Yu-ning Wang, Yan Li, Chuan-min Chu, Jing Zhang, Xiu-wu Pan, Chuan-yi Hu, Jing-cun Zheng, Ning Jiang, Xiao-jing Ma and Xin-gang Cui
Government of the People's Republic of China - Department of Urinary Surgery, Shanghai Jiao Tong University (SJTU) - School of Medicine, Ningxia Medical University, Ningxia Medical University, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Naval Medical University (SMMU), Government of the People's Republic of China - Department of Urinary Surgery, Cornell University - Department of Microbiology and Immunology and Government of the People's Republic of China - Department of Urinary Surgery
Downloads 151 (491,334)

Abstract:

Loading...

Renal Cell Carcinoma; Degalactotigonin; YAP; Sunitinibresistance; Metastasis

2.

Gankyrin is a Novel Biomarker for Disease Progression and Prognosis of Patients with Renal Cell Carcinoma

, EBioMedicine, Volume 39, January 2019, Pages 255-264, https://doi.org/10.1016/j.ebiom.2018.12.011
Number of pages: 48 Posted: 06 Nov 2018
Chao Wang, Yan Li, Xiang-min Zhang, Jie Ma, Hai Huang, Yu-ning Wang, Tian-yu Hong, Jing Zhang, Xiu-wu Pan, Chuan-min Chu, Jing-cun Zheng, Ning Jiang, Chuan-yi Hu, Xiao-jing Ma and Xin-gang Cui
Government of the People's Republic of China - Department of Urinary Surgery, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Shanghai Jiao Tong University (SJTU) - Department of Urinary Surgery, Ningxia Medical University, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Naval Medical University (SMMU), Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Cornell University - Department of Microbiology and Immunology and Government of the People's Republic of China - Department of Urinary Surgery
Downloads 117 (608,822)

Abstract:

Loading...

Renal cell carcinoma; gankyrin; prognosis; disease progression